Friday, February 12, 2021

Pharma Reviews: Glenmarks consolidated Net Profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21

Glenmark Pharmaceuticals Limited, a research-led global integrated ... with growth of 15.8% as compared to IPM (Indian Pharma market) growth of ...
Read more: Glenmarks consolidated Net Profit rises by 30.05% to Rs. 2481.79 Mn. in Q3 FY 2020-21